Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Galanin — a novel biologically active peptide from porcine intestine

Tatemoto, K., Rökaeus, Å., Jörnvall, H., McDonald, T. J., & Mutt, V. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80033-7 · Cited by 1,490 · see citing works

The Clinical Diagnosis of Alzheimer's Disease

Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416 · see citing works

A receptor subtype involved in neuropeptide-Y-induced food intake

Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl‐Hartmann, C., Smith, K. E., Vaysse, P. J. ‐., Durkin, M. M., Laz, T. M., Linemeyer, D. L., et al. (1996) · Nature · doi:10.1038/382168a0 · Cited by 891 · see citing works

Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis

Gustafson, L. (1987) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(87)90022-7 · Cited by 389 · see citing works

Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY

Bard, J., Walker, M. W., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26762 · Cited by 377 · see citing works

Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies.

Fisone, G., Wu, C. F., Consolo, S., Nordström, Ö., Brynne, N., Bartfai, T., Melander, T., & Hökfelt, T. G. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7339 · Cited by 344 · see citing works

Molecular cloning of a functional human galanin receptor.

Habert, E., Amiranoff, B., Loquet, I., Laburthe, M., & Mayaux, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9780 · Cited by 340 · see citing works

Post-source decay analysis in matrix-assisted laser desorption/ionization mass spectrometry of biomolecules

Spengler, B. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199711)32:10 · Cited by 321 · see citing works

Galanin hyperinnervates surviving neurons of the human basal nucleus of meynert in dementias of alzheimer's and parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia

Chan‐Palay, V. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902730409 · Cited by 273 · see citing works

Galanin--a neuroendocrine peptide.

Bartfai, T., Hökfelt, T. G. M., & Langel, Ü. (1993) · PubMed · Cited by 247 · see citing works

Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY

Wahlestedt, C., Regunathan, S., & Reis, D. J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90342-m · Cited by 183 · see citing works

Reduced lumbar CSF somatostatin in levels in Alzheimer's disease

Wood, P. L., Etienne, P. E., Lal, S., Gauthier, S. G., Cajal, S., & Nair, N. P. V. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90099-6 · Cited by 181 · see citing works

Volume Transmission in the Brain

Weissman, J. D. (1992) · Neurology · doi:10.1212/wnl.42.7.1440-b · Cited by 175 · see citing works

Distribution of galanin-like immunoreactivity in the human brain

Gentleman, S., Falkai, P., Bogerts, B., Herrero, M. T., Polak, J. M., & Roberts, G. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)91458-3 · Cited by 99 · see citing works

Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin

Raskind, M. A. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040092013 · Cited by 92 · see citing works

Low levels of somatostatin in human CSF mark depressive episodes

Ågren, H., & Lundqvist, G. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90003-9 · Cited by 86 · see citing works

HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro

Ruppert, D., & Weithmann, K. U. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90095-9 · Cited by 82 · see citing works

Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type

Martignoni, E., Blandini, F., Petraglia, F., Pacchetti, C., Bono, G., & Nappi, G. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260903 · Cited by 75 · see citing works

Hypothalamic degradation of galanin(1–29) and galanin(1–16): identification and characterization of the peptidolytic products

Land, T., Langel, Ü., & Bartfai, T. (1991) · Brain Research · doi:10.1016/0006-8993(91)90775-q · Cited by 64 · see citing works

CSF somatostatin in Alzheimer's disease and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measures

Molchan, S. E. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90044-l · Cited by 60 · see citing works

Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients

Nilsson, C. L., Karlsson, G., Blennow, K., Heilig, M. A., & Ekman, R. (1996) · Peptides · doi:10.1016/0196-9781(96)00013-7 · Cited by 60 · see citing works

Neuropeptide Y and neuropeptide Y18‐36 Structural and biological characterization

Boublik, J. H., SCOTT, N., Taulane, J. P., Goodman, M., Brown, M., & Rivier, J. (1989) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1989.tb00677.x · Cited by 57 · see citing works

Neuropeptides in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Dementia with Frontotemporal Lobe Degeneration

Edvinsson, L. I., Minthon, L., Ekman, R., & Gustafson, L. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107318 · Cited by 56 · see citing works

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

Heilig, M. A., Sjögren, M. J. C., Blennow, K., Ekman, R., & Wallin, A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00239-y · Cited by 47 · see citing works

Mass Spectrometry of Peptides in Neuroscience

Nilsson, C. L., Karlsson, G., Bergquist, J., Brinkmalm, A., & Ekman, R. (1998) · Peptides · doi:10.1016/s0196-9781(97)00471-3 · Cited by 45 · see citing works

Neuropeptide-Processing, -Converting, and -Inactivating Enzymes in Human Cerebrospinal Fluid

Terenius, L. Y., & Nyberg, F. (1988) · International review of neurobiology · doi:10.1016/s0074-7742(08)60047-1 · Cited by 43 · see citing works

Multiple forms of somatostatin-like immunoreactivity in the hypothalamus and amygdala of the rat: selective localization of somatostatin-28 in the median eminence

Pierotti, A. R., & Harmar, A. J. (1985) · Journal of Endocrinology · doi:10.1677/joe.0.1050383 · Cited by 40 · see citing works

CSF Somatostatin in alzheimer's disease, depressed patients, and control subjects

Davis, K. L., Davidson, M., Yang, R.-K., Davis, B. M., Siever, L. J., Mohs, R. C., Ryan, T. M., Coccaro, E., Bierer, L. M., & Targum, S. D. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90147-3 · Cited by 39 · see citing works

Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats

Persson, S., Post, C., Alari, L., Nyberg, F., & Terenius, L. Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90838-0 · Cited by 37 · see citing works

Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man

Maeda, K., Yasuda, M., Kaneda, H., Maeda, S., & Yamadori, A. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90058-2 · Cited by 35 · see citing works

Effects of chlordiazepoxide and β-carboline 3-carboxylic acid ethyl ester on non-suppressed and minimally-suppressed responding in the squirrel monkey

Glowa, J. R., & Insel, T. R. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90191-q · Cited by 34 · see citing works

Galanin and Galanin Extended at the N-Terminus with Seven and Nine Amino Acids Are Produced in and Secreted from the Porcine Adrenal Medulla in almost Equal Amounts*

Bersani, M., Thim, L., Rasmussen, T. N., & Holst, J. J. (1991) · Endocrinology · doi:10.1210/endo-129-5-2693 · Cited by 23 · see citing works

Analysis of proenkephalin A, proopiomelanocortin and protachykinin neuropeptides in human lumbar cerebrospinal fluid by reversed-phase high-performance liquid chromatography, radioimmunoassay and enzymolysis

Harajiri, S., Wood, G. W., & Desiderio, D. M. (1992) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(92)80148-j · Cited by 22 · see citing works

Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry

Nilsson, C. L., Brinkmalm, A., Blennow, K., & Ekman, R. (1998) · Peptides · doi:10.1016/s0196-9781(98)00071-0 · Cited by 21 · see citing works

Novel Neuropeptide Y Processing in Human Cerebrospinal Fluid From Depressed Patients

Ekman, R., Juhász, P., Heilig, M. A., ÅGREN, H., & Costello, C. E. (1996) · Peptides · doi:10.1016/s0196-9781(96)00168-4 · Cited by 21 · see citing works

Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy

Malessa, R., Heimbach, M., Brockmeyer, N. H., Hengge, U. R., Rascher, W., & Michel, M. C. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00305-l · Cited by 19 · see citing works

Neuropeptide converting enzyme activities in CSF of low back pain patients

Hyyppä, M. T., Alaranta, H., Lahtela, K., Nykvist, F., Hurme, M., Nyberg, F., Grevès, P. L., Sakurada, T., & Terenius, L. Y. (1990) · Pain · doi:10.1016/0304-3959(90)91069-u · Cited by 19 · see citing works

Capillary liquid chromatography—fast atom bombardment mass spectrometry using a high-resolving cation exchanger, based on a continuous chromatographic matrix Application to studies on neuropeptide peptidases

Li, Y.-M., Brostedt, P., Hjertén, S., Nyberg, F., & Silberring, J. (1995) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00478-n · Cited by 16 · see citing works

CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia

Bánki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90137-r · Cited by 15 · see citing works

Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide y in multiple sclerosis

Vécsei, L., Csala, B., Widerlöv, E., Ekman, R., Czopf, J., & Pálffy, G. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90229-s · Cited by 14 · see citing works

Neuropeptide-converting enzymes in cerebrospinal fluid:Activities increased in pain from herniated lumbar disc, but not from coxarthrosis

Lindh, C., Thörnwall, M., Hansen, A.-C., Post, C., Gordh, T., Ordeberg, G., & Nyberg, F. (1996) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679608994670 · Cited by 13 · see citing works

Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients

Rißler, K., Jost, S., Mohadjer, M., Mundinger, F., & Cramer, H. (1987) · Neuroscience Research · doi:10.1016/0168-0102(87)90001-0 · Cited by 8 · see citing works

Reduced Lumbar Cerebrospinal Fluid Somatostatin Levels in Alzheimer's Disease and Dementia with Frontotemporal Degeneration

Minthon, L., Edvinsson, L. I., Ekman, R., & Gustafson, L. (1991) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107216 · Cited by 7 · see citing works

Assay of Preproenkephalin A Processing Enzymes in Human Lumbar Cerebrospinal Fluid

Kaneko, T., Wood, G. W., Crouch, W. L., & Desiderio, D. M. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1552 · Cited by 6 · see citing works

Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity

Lang, R., Gundlach, A. L., Holmes, F. E., Hobson, S. A., Wynick, D., Hökfelt, T., & Kofler, B. (2015) · Pharmacological Reviews · doi:10.1124/pr.112.006536 · Cited by 327 · see citing works

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry

Marvin, L., Roberts, M., & Fay, L. B. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.08.008 · Cited by 225 · see citing works

Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease

Ramos, B., Baglietto‐Vargas, D., del Río, J. C., Moreno‐González, I., Santa‐María, C., Jiménez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 213 · see citing works

Chronic Administration of Statins Alters Multiple Gene Expression Patterns in Mouse Cerebral Cortex

Johnson‐Anuna, L. N., Eckert, G. P., Keller, J. H., Igbavboa, U., Franke, C., Fechner, T., Schubert‐Zsilavecz, M., Karas, M., Müller, W. E., & Wood, W. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075028 · Cited by 199 · see citing works

Neuropeptides in learning and memory

Borbély, É., Scheich, B., & Helyes, Z. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.012 · Cited by 166 · see citing works

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases

Duarte‐Neves, J., de Almeida, L. P., & Cavadas, C. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.022 · Cited by 137 · see citing works

Alzheimer disease pathology and the cerebrospinal fluid proteome

Dayon, L., Núñez Galindo, A., Wojcik, J., Cominetti, O., Corthésy, J., Oikonomidi, A., Henry, H., Kussmann, M., Migliavacca, E., Severin, I., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0397-4 · Cited by 101 · see citing works

Neuropeptide Y Fragments Derived from Neprilysin Processing Are Neuroprotective in a Transgenic Model of Alzheimer's Disease

Rose, J. B., Crews, L. A., Rockenstein, E. M., Adame, A., Mante, M., Hersh, L. B., Gage, F. H., Spencer, B. J., Potkar, R., Marr, R. A., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4220-08.2009 · Cited by 94 · see citing works

Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ1–40) administration in mice

dos Santos, V. V., Santos, D. B., Lach, G., Rodrigues, A. L. S., Farina, M., de Lima, T. C. M., & Prediger, R. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.039 · Cited by 92 · see citing works

Somatostatin and Alzheimer's disease

Burgos‐Ramos, E., Hervás‐Aguilar, A., Aguado‐Llera, D., Puebla‐Jiménez, L., Hernández‐Pinto, A. M., Barrios, V., & Arilla, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.014 · Cited by 87 · see citing works

Expression of somatostatin receptor subtypes (SSTR1–5) in Alzheimer’s disease brain: An immunohistochemical analysis

Kumar, U. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.001 · Cited by 101 · see citing works

Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease

Saiz-Sanchez, D., De la Rosa-Prieto, C., Ubeda-Banon, I., & Martinez-Marcos, A. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0771-3 · Cited by 79 · see citing works

Expression of Somatostatin, Cortistatin, and Their Receptors, as well as Dopamine Receptors, but not of Neprilysin, are Reduced in the Temporal Lobe of Alzheimer's Disease Patients

Gahete, M. D., Rubio, A., Durán‐Prado, M., Ávila, J., Luque, R. M., & Castano, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1385 · Cited by 73 · see citing works

An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology

Cervia, D., & Bagnoli, P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.010 · Cited by 72 · see citing works

Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease

Rangani, R. J., Upadhya, M. A., Nakhate, K. T., Kokare, D. M., & Subhedar, N. K. (2012) · Peptides · doi:10.1016/j.peptides.2012.01.004 · Cited by 66 · see citing works

Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo

Śmiałowska, M., Domin, H., Zieba, B. A., Koźniewska, E., Michalik, R., Piotrowski, P., & Kajta, M. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.02.002 · Cited by 65 · see citing works

Cerebrospinal fluid-contacting neurons: multimodal cells with diverse roles in the CNS

Wyart, C., Tano, M. C., Cantaut-Belarif, Y., Orts-Del’Immagine, A., & Böhm, U. L. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00723-8 · Cited by 65 · see citing works

Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease

Peineau, S., Rabiant, K., Pierrefiche, O., & Potier, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.018 · Cited by 53 · see citing works

Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.

Štrac, D. Š., Mück‐Šeler, D., & Pivac, N. (2015) · PubMed · Cited by 51 · see citing works

Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD

Tundo, G., Ciaccio, C., Sbardella, D., Boraso, M., Viviani, B., Coletta, M., & Marini, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034376 · Cited by 50 · see citing works

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Leko, M. B., Štrac, D. Š., Mück‐Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.347 · Cited by 46 · see citing works

Top‐down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time‐of‐flight tandem mass spectrometry

Möhring, T., Kellmann, M., Jürgens, M., & Schrader, M. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.741 · Cited by 40 · see citing works

Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies

Björefeldt, A., Illes, S., Zetterberg, H., & Hanse, E. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00005 · Cited by 37 · see citing works

C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling

Somvanshi, R. K., Billová, S., Kharmate, G., Rajput, P. S., & Kumar, U. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.04.007 · Cited by 36 · see citing works

Cerebrospinal Fluid Neuropeptide Y-like Immunoreactivity Correlates with Impulsive Aggression in Human Subjects

Coccaro, E. F., Lee, R., Liu, T., & Mathé, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.029 · Cited by 34 · see citing works

Somatostatin and Cognitive Function in Neurodegenerative Disorders

Tuboly, G., & Vécsei, L. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955713804484794 · Cited by 31 · see citing works

Proteomics and peptidomics in neuroscience. Experience of capabilities and limitations in a neurochemical laboratory

Paulson, L., Persson, R., Karlsson, G., Silberring, J., Bierczyńska-Krzysik, A., Ekman, R., & Brinkmalm, A. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.740 · Cited by 29 · see citing works

Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory

Mirchandani-Duque, M., Barbancho, M., López-Salas, A., Alvarez-Contino, J. E., García-Casares, N., Fuxe, K., Borroto-Escuela, D., & Narváez, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061297 · Cited by 24 · see citing works

Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats

Borroto-Escuela, D., Fores, R., Pita, M., Barbancho, M., Zamorano-González, P., Casares, N. G., Fuxe, K., & Narváez, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.820210 · Cited by 23 · see citing works

Genetic mechanisms underlying brain functional homotopy: a combined transcriptome and resting-state functional MRI study

Zhao, H., Cai, H., Mo, F., Lu, Y., Yao, S., Yu, Y., & Zhu, J. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac279 · Cited by 25 · see citing works

Somatostatin in Medium-Sized Aspiny Interneurons of Striatum is Responsible for Their Preservation in Quinolinic Acid and N-Methyl-d-Asparate-Induced Neurotoxicity

Kumar, U. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9093-3 · Cited by 22 · see citing works

Neuropeptide Y ( NPY ) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY 1–30fragment

Wagner, L., Björkqvist, M., Lundh, S. H., Wolf, R., Börgel, A., Schlenzig, D., Ludwig, H., Rahfeld, J., Leavitt, B. R., Demuth, H., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13624 · Cited by 21 · see citing works

Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw)

Crawford, F., Wood, M., Ferguson, S., Mathura, V. S., Faza, B., Wilson, S., Fan, T., O'Steen, B. E., Ait‐Ghezala, G., Hayes, R. L., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.042 · Cited by 20 · see citing works

Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner

Kannan, M., Steinert, J. R., Forsythe, I. D., Smith, A. G., & Chernova, T. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.004 · Cited by 20 · see citing works

Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids

Chatterjee, D., Jacob, R. S., Ray, S., Navalkar, A., Singh, N., Sengupta, S., Gadhe, L. G., Kadu, P., Datta, D., Paul, A., et al. (2022) · eLife · doi:10.7554/elife.73835 · Cited by 19 · see citing works

ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling

Tayran, H., Yılmaz, E., Bhattarai, P., Min, Y.-H., Wang, X., Ma, Y.-Y., Wang, N., Jeong, I., Nelson, N., Kassara, N., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100642 · Cited by 17 · see citing works

The Protective Effects of IGF-I against β-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A

Aguado‐Llera, D., Canelles, S., Frago, L. M., Chowen, J. A., Argente, J., Arilla, E., & Barrios, V. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.041 · Cited by 18 · see citing works

Reduction in Aβ‐induced cell death in the hippocampus of 17β‐estradiol‐treated female rats is associated with an increase in IGF‐I signaling and somatostatinergic tone

Perianes‐Cachero, A., Canelles, S., Aguado‐Llera, D., Frago, L. M., Toledo-Lobo, M. V., Carrera, I., Cacabelos, R., Chowen, J. A., Argente, J., Arilla, E., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13381 · Cited by 16 · see citing works

The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouseanorexia(anx) mutation

Kim, D. Y., Yu, J., Mui, R. K., Niibori, R., Taufique, H. B., Aslam, R., Semple, J. W., & Cordes, S. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027433 · Cited by 16 · see citing works

Regulatory effects of galanin system on development of several age-related chronic diseases

Fang, P., Yu, M., Wan, D., Zhang, L., Han, L., Shen, Z., Shi, M., Zhu, Y. N., Zhang, Z., & Bo, P. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.04.009 · Cited by 16 · see citing works

Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion.

Díaz-Sánchez, E., López-Salas, A., Mirchandani-Duque, M., Alvarez-Contino, J. E., Sánchez-Pérez, J. A., Fuxe, K., Borroto-Escuela, D., García-Casares, N., & Narváez, M. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.114433 · Cited by 12 · see citing works

Analysis of substance P in rat brain by means of immunoaffinity capture and matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry

Babu, C. V. S., Lee, J., Lho, D. S., & Yoo, Y. S. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.04.026 · Cited by 13 · see citing works

Water maze impairments after combined depletion of somatostatin and serotonin in the rat

Dyer, K., & Cain, D. P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.029 · Cited by 12 · see citing works

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14 · see citing works

Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer’s disease

Zhang, Z., Fang, P., Shi, M., Zhu, Y. N., & Bo, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.08.001 · Cited by 11 · see citing works

Effect of cortistatin on tau phosphorylation at Ser262 site

Rubio, A., Pérez, M., de Lecea, L., & Ávila, J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21689 · Cited by 11 · see citing works

Determination of Substance P by capillary zone electrophoresis in rat brain

Babu, C. V. S., Han, K.-Y., Kim, Y., & Yoo, Y. S. (2003) · Microchemical Journal · doi:10.1016/s0026-265x(03)00051-1 · Cited by 10 · see citing works

Signalling of galanin and amyloid precursor protein through adenylate cyclase

Mahlapuu, R. (2004) · DSpace repository (University of Tartu) · Cited by 10 · see citing works

Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions

Sanchez-Varo, R., López-Salas, A., Beltran-Casanueva, R., Díaz-Sánchez, E., Alvarez-Contino, J. E., Barbancho-Fernández, M. A., Castro, P. S., Fuxe, K., Borroto-Escuela, D., García-Casares, N., et al. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00230-5 · Cited by 9 · see citing works

Plasma neuropeptide Y and cognitive impairment after acute ischemic stroke

Dong, W., Lu, Y., Zhai, Y., Bi, Y., Peng, Y., Ju, Z., Xu, T., Zhong, X., Zhang, Y., & Zhong, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.052 · Cited by 9 · see citing works

Somatostatin Ameliorates β-Amyloid-Induced Cytotoxicity via the Regulation of CRMP2 Phosphorylation and Calcium Homeostasis in SH-SY5Y Cells

Paik, S., Somvanshi, R. K., Oliveira, H. A., Zou, S., & Kumar, U. (2021) · Biomedicines · doi:10.3390/biomedicines9010027 · Cited by 9 · see citing works

Exposure to aluminium changes the NADPH-diaphorase/ NPY pattern in the rat cerebral cortex

Rodella, L. F., Ricci, F., Borsani, E., Rezzani, R., Stacchiotti, A., Mariani, C., & Bianchi, R. (2006) · Archivum histologicum japonicum · doi:10.1679/aohc.69.13 · Cited by 9 · see citing works

Specific changes of somatostatin mRNA expression in the frontal cortex and hippocampus of diabetic rats

XiaoMing, Z., Xi, Z., Fang, S., & Jilin, Z. (2004) · Journal of Anatomy · doi:10.1111/j.0021-8782.2004.00273.x · Cited by 9 · see citing works

Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer’s disease

Kölsch, H., Lütjohann, D., Jessen, F., Urbach, H., von Bergmann, K., Maier, W., & Heun, R. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0319-z · Cited by 9 · see citing works

Peptides as drug candidates against Alzheimer's disease

Gozes, I., & Spier, A. D. (2002) · Drug Development Research · doi:10.1002/ddr.10103 · Cited by 8 · see citing works

Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats

Arrabal-Gómez, C., Beltran-Casanueva, R., Hernández-García, A., Bayolo-Guanche, J. V., Barbancho-Fernández, M. A., Castro, P. S., & Narváez, M. (2024) · Cells · doi:10.3390/cells13080669 · Cited by 7 · see citing works

The intracellular mobility of NPY and a putative mitochondrial form of NPY in neuronal cells

Kaipio, K., & Pesonen, U. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.018 · Cited by 7 · see citing works

Graphene nanosheet mediated MALDI-MS (GN-MALDI-MS) for rapid, in situ detection of intact incipient biofilm on material surfaces

Sgum, W. B., Gopal, J., Hua, P.-Y., & Wu, H. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.04.053 · Cited by 6 · see citing works

Changes of the Primary Cilia in Alzheimer's Disease Pathogenesis

Guo, A., Wang, H., Zhang, Y., & Huang, H. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70125 · Cited by 7 · see citing works

ABCA7‐dependent Neuropeptide‐Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer’s disease

Tayran, H., Yılmaz, E., Bhattarai, P., Min, Y., Wang, X., Ma, Y., Nelson, N. N., Kassara, N., Coşacak, M. İ., Dogru, R. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.089273 · Cited by 6 · see citing works

Neuroprotective Effects of Vapreotide on Tau Transfection–Induced Neurodegeneration

Uzunhisarcıklı, E., & Yerer, M. B. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00588-2 · Cited by 4 · see citing works

NPY and chronic neurodegenerative disease

Colton, C. A., & Vitek, M. P. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7417-9_17 · Cited by 4 · see citing works

Expression of somatostatin and its receptor�1‑5 in endometriotic tissues and cells

Zhao, Y., Peng, L., Li, X., & Zhang, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6730 · Cited by 4 · see citing works

The effect of Neuropeptide Y Y2 receptor blockade on memory impairment and autophagy in a rat model of Alzheimer’s disease

Esfaniari, E., Hosseinkhani, A., Rashtiani, S., Rohampour, K., & Jafari, A. (2024) · Physiology and Pharmacology · doi:10.61186/phypha.28.2.117 · Cited by 2 · see citing works

Peripheral expression of NPY1R-based heteroreceptor complexes reflects hippocampal neuroimmune status: Novel biomarkers for early Alzheimer’s disease detection

Moreno-Madrid, I., Romero-Imbroda, J., Bueno, J. A. R., Arrabal-Gómez, C., Díaz-Casares, A., Díaz‐Sánchez, E., Barbancho-Fernández, M. Á., Fuxé, K., Borroto-Escuela, D., Serrano-Castro, P. J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118332 · Cited by 2 · see citing works

A coral-derived neuropeptide suppresses pentylenetetrazol (PTZ)-induced epileptic seizures and improves recognition memory deficits by modulating NPY-Y1R

Chen, Q., Deng, C., Huang, X., Wang, A., Xu, N., Cao, K., Yang, M., Li, S., Lu, Q., Gong, G., et al. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04164-3 · Cited by 2 · see citing works

A novel bifunctional peptide predicted to target neuropeptide Y4 and GLP-1 receptors alleviates cognitive deficits in 5 × FAD mice by modulating cGAS-STING-mediated neuroinflammation

Feng, Y., 张彩利, Wei, Y., Liu, E., Sun, H., Flatt, P., Gault, V. A., Irwin, N., Hölscher, C., Hao, L., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118074 · Cited by 2 · see citing works

Molecular Diagnostics in Transfusion Medicine: MALDI-TOF MS for Blood Bankers- The Alternative Approach for Genotyping

Molan, A. (2014) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-09229097 · Cited by 2 · see citing works

Neuroprotective Effects of Neuropeptide Y and Y2 and Y5 Receptor Agonists In Vitro and In Vivo

Śmiałowska, M., & Domin, H. (2012) · InTech eBooks · doi:10.5772/34717 · Cited by 2 · see citing works

The role of galanin/GALR2 signaling in the link between type 2 diabetes and Alzheimer's disease

Xu, M., Wang, J., She, Y., He, J., Yu, M., Zhang, Z., & Fang, P. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102586 · Cited by 1 · see citing works

Growth Hormone and Insulin-like Growth Factor-I in Alzheimer's Disease

Gómez, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088484-1/50026-4 · Cited by 1 · see citing works

Growth Hormone and Insulin-Like Growth Factor-I in Alzheimer's Disease

Saez, J. M. G. (2012) · The Open Endocrinology Journal · doi:10.2174/1874216501206010080

The Analyses of Neurotransmitters, Other Neuroactive Substances, and Their Metabolites Using Mass Spectrometry

Sloley, B. D., Rauw, G. A., & Coutts, R. T. (2006) · Springer eBooks · doi:10.1007/978-0-387-30401-4_6

Expression of somatostatin and its receptor (SSTR) 1-5 gene in ectopic endormetrotic tissues and cells

Hou, P., Chen, L., Liu, H., Zhang, W., & Yansheng, L. (2017) · Biomedical Research-tokyo

LC-MS Analysis of Endogenous Neuropeptides from Tissues of Central Nervous System: An Overview

Alasağ, N., & Şener, E. (2024) · Applications of modern mass spectrometry · doi:10.2174/9789815050059122020006

Additional file 1 of Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions

Sanchez-Varo, R. M., López‐Salas, A., Beltran-Casanueva, R., Díaz‐Sánchez, E., Alvarez‐Contino, J. E., Barbancho-Fernández, M. Á., Serrano-Castro, P., Fuxé, K., Borroto-Escuela, D. O., García-Casares, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26699204

Différences mâles/femelles dans les effets de l'éthanol sur la plasticité hippocampique chez le rat adolescent : rôle des œstrogènes

Rabiant, K. (2020) · theses.fr (ABES) · doi:10.70675/d97d79f9z943fz4874z9d8bzd6c690108632

Interoceptive chemosensory functions of neurons in contact with the cerebrospinal fluid

Marnas, H. (2021) · doi:10.70675/090bfaa3zfeccz45fezbaadz4bb15ac06dd4

P1642-1, a novel pancreatic polypeptide analogue, ameliorates cognitive impairment in 5 ×FAD mice and is associated with enhanced PINK1/Parkin-related mitophagy

Zhang, H., Wei, Y., Liu, E., Sun, H., Flatt, P., Gault, V. A., Irwin, N., Hölscher, C., Hao, L., & Zhang, Z. (2026) · Peptides · doi:10.1016/j.peptides.2026.171501

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations with Severity of Disease and Clinical Signs in Alzheimer's Disease and Frontotemporal Dementia

Minthon, L., Edvinsson, L. I., & Gustafson, L. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106636 · Cited by 26 · see citing works

Neuropeptides in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Dementia with Frontotemporal Lobe Degeneration

Edvinsson, L. I., Minthon, L., Ekman, R., & Gustafson, L. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107318 · Cited by 56 · see citing works

Neuropeptide levels in Alzheimer’s disease and dementia with frontotemporal degeneration

Minthon, L., Edvinsson, L. I., Ekman, R., & Gustafson, L. (1990) · Springer eBooks · doi:10.1007/978-3-7091-3345-3_6 · Cited by 30 · see citing works

Cerebrospinal Fluid Neuropeptide Y-Like Immunoreactive Levels in Dementia of Alzheimer Type and Dementia with Frontotemporal Degeneration of Non-Alzheimer Type

Minthon, L., Edvinsson, L. I., Ekman, R., & Gustafson, L. (1990) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107150 · Cited by 2 · see citing works

Cerebrospinal Fluid Somatostatin and Neuropeptide Y

Atack, J. R. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520270043019 · Cited by 68 · see citing works